Older Medical Trials Still Hold Future Promise

Older Medical Trials Still Hold Future Promise

As powerful as new precision medicine trials may be, researchers should not dismiss the importance of older and established long-term research trials, says Dr. Meir Stampfer of Brigham and Women’s Hospital, principle investigator for the famed Nurses’ Health Study.

Stampfer notes that precision medicine trials based in hospitals or health systems have limitations that broad-based, long-term trials like the 40-year-old nurses’ study and its groundbreaking predecessor, the Framingham Heart Study, do not. Perhaps the most significant is that hospital-based trials, such as Geisinger Health System’s MyCode Community Health Initiative, enroll a population of volunteers that is skewed toward people who visit the hospital for treatment.

View the full story in U.S. News & World Report



X